Detailed information for compound 140839

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 241.24 | Formula: C11H15NO5
  • H donors: 3 H acceptors: 3 LogP: -0.78 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: COC(=O)c1cc(oc1C)C1NCC(C1O)O
  • InChi: 1S/C11H15NO5/c1-5-6(11(15)16-2)3-8(17-5)9-10(14)7(13)4-12-9/h3,7,9-10,12-14H,4H2,1-2H3
  • InChiKey: PWMHDFWOBAXQDM-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens fucosidase, alpha-L- 1, tissue Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis fucosidase, alpha L 1, tissue Get druggable targets OG5_129683 All targets in OG5_129683
Schistosoma mansoni alpha-l-fucosidase Get druggable targets OG5_129683 All targets in OG5_129683
Loa Loa (eye worm) alpha-L-fucosidase Get druggable targets OG5_129683 All targets in OG5_129683
Mycobacterium ulcerans alpha-L-fucosidase Get druggable targets OG5_129683 All targets in OG5_129683
Schistosoma japonicum ko:K01206 alpha-L-fucosidase [EC3.2.1.51], putative Get druggable targets OG5_129683 All targets in OG5_129683
Echinococcus granulosus fucosidase alpha L 1 tissue Get druggable targets OG5_129683 All targets in OG5_129683
Brugia malayi Alpha-L-fucosidase family protein Get druggable targets OG5_129683 All targets in OG5_129683

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium falciparum ADP-dependent DNA helicase RecQ 0.0022 0.0332 1
Trypanosoma cruzi ATP-dependent DEAD/H DNA helicase recQ, putative 0.0014 0.0161 0.5
Toxoplasma gondii ATP-dependent DNA helicase, RecQ family protein 0.0011 0.0101 0.4422
Brugia malayi Bloom's syndrome protein homolog 0.0025 0.0393 0.0495
Schistosoma mansoni alpha-l-fucosidase 0.0313 0.6005 1
Leishmania major ATP-dependent DEAD/H DNA helicase recQ, putative 0.0014 0.0161 0.5
Echinococcus multilocularis fucosidase, alpha L 1, tissue 0.0517 1 1
Schistosoma mansoni blooms syndrome DNA helicase 0.002 0.0288 0.048
Schistosoma mansoni DNA helicase recq1 0.0011 0.0101 0.0168
Plasmodium vivax ADP-dependent DNA helicase RecQ, putative 0.0017 0.0232 0.5
Echinococcus multilocularis bloom syndrome protein 0.0025 0.0393 0.0295
Loa Loa (eye worm) RecQ helicase 0.0025 0.0393 0.0495
Echinococcus granulosus bloom syndrome protein 0.0025 0.0393 0.0295
Trichomonas vaginalis DNA helicase recq1, putative 0.0025 0.0393 0.096
Giardia lamblia Sgs1 DNA helicase, putative 0.0011 0.0101 0.5
Brugia malayi Alpha-L-fucosidase family protein 0.0313 0.6005 1
Mycobacterium ulcerans alpha-L-fucosidase 0.0517 1 0.5
Trypanosoma brucei ATP-dependent DEAD/H DNA helicase recQ, putative 0.0014 0.0161 0.5
Trichomonas vaginalis alpha-L-fucosidase, putative 0.0137 0.2576 1
Trichomonas vaginalis DNA helicase recq, putative 0.0025 0.0393 0.096
Loa Loa (eye worm) hypothetical protein 0.002 0.0292 0.0324
Trichomonas vaginalis alpha-L-fucosidase, putative 0.0137 0.2576 1
Entamoeba histolytica recQ family helicase, putative 0.0014 0.0161 1
Toxoplasma gondii ATP-dependent DNA helicase, RecQ family protein 0.0011 0.0101 0.4422
Loa Loa (eye worm) alpha-L-fucosidase 0.0313 0.6005 1
Toxoplasma gondii ATP-dependent DNA helicase, RecQ family protein 0.0017 0.0228 1
Schistosoma mansoni hypothetical protein 0.0062 0.1101 0.1834
Schistosoma mansoni DNA helicase recq5 0.0011 0.0101 0.0168

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 100 uM Inhibitory concentration against alpha-L-Fucosidase of bovine epididymis ChEMBL. 11549468
IC50 (binding) = 100 uM Inhibitory concentration against alpha-L-Fucosidase of bovine epididymis ChEMBL. 11549468
IC50 (binding) = 150 uM Inhibitory concentration against alpha-L-Fucosidase of human placenta ChEMBL. 11549468
IC50 (binding) = 150 uM Inhibitory concentration against alpha-L-Fucosidase of human placenta ChEMBL. 11549468
IC50 (binding) = 800 uM Inhibitory concentration against Beta-D-galactosidase of bovine liver ChEMBL. 11549468
IC50 (binding) = 800 uM Inhibitory concentration against Beta-D-galactosidase of bovine liver ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against Beta-glucosidase of Caldocellum saccharolyticum at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against Beta-glucosidase of almonds at 1 mM; No inhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against Beta-mannosidase of Helix pomatia at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against Beta-D-galactosidase of Aspergillus niger at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against Beta-D-galactosidase of E. coli at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against maltase of rice at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against maltase of yeast at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against Beta-D-galactosidase of Aspergillus orizae at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against isomaltase of baker yeast at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against Beta-D-galactosidase of Jack bean at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) % Inhibitory activity against alpha-N-acetylgalactosaminidase of chicken liver at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Beta-D-galactosidase of Aspergillus niger at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Beta-D-galactosidase of Jack bean at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Alpha-galactosidase of Aspergillus niger at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Alpha-galactosidase of E. coli at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Beta-D-galactosidase of E. coli at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Beta-D-galactosidase of Aspergillus orizae at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against maltase of yeast at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against maltase of rice at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against isomaltase of baker yeast at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) 0 % Inhibitory activity against Beta-glucosidase of almonds at 1 mM; No inhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Beta-glucosidase of Caldocellum saccharolyticum at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against Beta-mannosidase of Helix pomatia at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) NI 0 % Inhibitory activity against alpha-N-acetylgalactosaminidase of chicken liver at 1 mM; Noinhibition ChEMBL. 11549468
Inhibition (binding) 0 % Inhibitory activity against Beta-N-acetylgalactosaminidase of Jack bean at 1 mM; No inhibition ChEMBL. 11549468
Inhibition (binding) 0 % Inhibitory activity against Beta-N-acetylgalactosaminidase of bovine epididymis A at 1 mM; No inhibition ChEMBL. 11549468
Inhibition (binding) 0 % Inhibitory activity against Beta-N-acetylgalactosaminidase of bovine epididymis B at 1 mM; No inhibition ChEMBL. 11549468
Inhibition (binding) = 23 % Percent inhibition against Amyloglucosidase of Aspergillus niger at 1 mM ChEMBL. 11549468
Inhibition (binding) = 23 % Percent inhibition against Alpha-mannosidase of Jack bean at 1 mM ChEMBL. 11549468
Inhibition (binding) = 23 % Percent inhibition against Amyloglucosidase of Aspergillus niger at 1 mM ChEMBL. 11549468
Inhibition (binding) = 33 % Percent inhibition against Amyloglucosidase of Rhizopus mold at 1 mM ChEMBL. 11549468
Inhibition (binding) = 33 % Percent inhibition against Amyloglucosidase of Rhizopus mold at 1 mM ChEMBL. 11549468
Inhibition (binding) = 36 % Percent inhibition against Alpha-mannosidase of Almonds at 1 mM ChEMBL. 11549468
Inhibition (binding) = 42 % Percent inhibition against Alpha-galactosidase of coffee bean at 1 mM ChEMBL. 11549468
Inhibition (binding) = 42 % Percent inhibition against Alpha-galactosidase of coffee bean at 1 mM ChEMBL. 11549468
Inhibition (binding) = 54 % Percent inhibition against Beta-D-galactosidase of bovine liver at 1 mM ChEMBL. 11549468
Inhibition (binding) = 54 % Percent inhibition against Beta-D-galactosidase of bovine liver at 1 mM ChEMBL. 11549468
Inhibition (binding) = 88 % Percent inhibition against alpha-L-Fucosidase of human placenta at 1 mM ChEMBL. 11549468
Inhibition (binding) = 88 % Percent inhibition against alpha-L-Fucosidase of human placenta at 1 mM ChEMBL. 11549468
Ki (binding) = 6.5 uM Inhibitory activity against alpha-L-Fucosidase of bovine epididymis expressed as Ki ChEMBL. 11549468
Ki (binding) = 6.5 uM Inhibitory activity against alpha-L-Fucosidase of bovine epididymis expressed as Ki ChEMBL. 11549468
Ki (binding) = 13.8 uM Inhibitory activity against alpha-L-Fucosidase of human placenta expressed as Ki ChEMBL. 11549468
Ki (binding) = 13.8 uM Inhibitory activity against alpha-L-Fucosidase of human placenta expressed as Ki ChEMBL. 11549468

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.